Drug Research
Daiichi And MSD Broaden DXd ADC Collaboration Worldwide
Daiichi Sankyo and MSD have widened their partnership to create and market three DXd-based antibody-drug conjugates (ADCs) all over the world.
DXd is the name...
Drug Research
With a $400M Deal: Ideaya Targets Biocytogens BsADC Program
For an option on Biocytogen Pharmaceuticals' possible first-in-class B7H3/PTK7 BsADC program, Ideaya Biosciences is paying more than $400 million. The goal of antibody drug...
Drug Research
Eli Lilly Invests In Actinium-225 To Support Radiopharma
The largest pharmaceutical company in the world based on market value, Eli Lilly, is getting into the nuclear isotope manufacturing industry as cancer medicine...
Drug Research
Regulatory Challenges In Radiopharmaceuticals And The CAGT
The life sciences industry is going through a big change right now, thanks to the fast growth of new treatments like cell and gene...
Drug Research
IAEA Unveils New Database For Global Radiopharmaceuticals
Research, cooperation, and the sustainability of safe radiopharmaceuticals for clinical application will be aided by a new IAEA radiopharmacy database. To compile into the...
Drug Research
How Are ADCs Improving Cancer Treatments With Precision
ADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs are made up of...
Drug Research
Antibody Drug Conjugates: Future Therapies And Treatment
Beyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity to deliver therapeutic drugs...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read